Announcements

  1. Call for Papers: Special Edition on Emerging Cancer Therapies

The Asia Pacific Journal of Cancer Research (APJCR) is pleased to announce a call for papers for a special edition focusing on "Emerging Cancer Therapies in the Asia-Pacific Region." This edition highlights the latest advancements in cancer treatment, including novel drug developments, immunotherapies, targeted therapies, and personalized medicine approaches. Researchers and clinicians are encouraged to submit original research articles, reviews, and case reports. 

  1. APJCR Joins CrossRef for DOI Assignment

We are excited to inform our contributors and readers that APJCR has partnered with CrossRef to assign Digital Object Identifiers (DOIs) to all published articles. This will enhance the discoverability and citation of our content, ensuring that research published in APJCR is easily accessible and recognized globally. Authors of previously published articles will also receive DOIs for their work retroactively.

  1. Upcoming Workshop: Ethical Publishing Practices

APJCR will host an "Ethical Publishing Practices in Scientific Research" workshop. This workshop is designed for authors, reviewers, and editors interested in understanding best practices for ethical research publication. Topics will include plagiarism prevention, conflict of interest management, and the peer review process. Registration details will be available soon on our website.

  1. Increase in Impact Factor

We are proud to announce that APJCR's impact factor has increased, reflecting the high quality and relevance of our published research. We thank our authors, reviewers, and editorial board members for contributing to this achievement. We look forward to continuing to publish impactful research that advances the field of oncology in the Asia-Pacific region.

  1. Reminder: Submission Guidelines Update

Authors are reminded to review the updated submission guidelines on our website before submitting their manuscripts. The updates include new requirements for data availability statements, conflict of interest disclosures, and structured abstracts. These changes are part of our ongoing efforts to enhance the transparency and integrity of our published research.